Bedford Pharmacy Recalls Testosterone Cypionate Injections Due to Sterility Concerns
Bedford Pharmacy is recalling Testosterone Cypionate injections due to a lack of assurance of sterility. The affected products were distributed in New Hampshire and Massachusetts.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.
Plain-English summary
Bedford Pharmacy is recalling specific lots of Testosterone Cypionate (Complete Formula) 100 mg/mL injections. The recall was initiated because there is a lack of assurance of sterility for the affected products.
The recalled items include 3 vials of the injection. The specific lot numbers are 09082015@12 (expiration date 10/23/2015) and 09032015@16 (expiration date 10/18/2015). These products were distributed in New Hampshire and Massachusetts.
Consumers who have these specific products should stop using them and contact their healthcare provider or Bedford Pharmacy for further instructions.
The recalled product
- Product
- Testosterone Cypionate (Complete Formula) 100 mg/mL, Injection, Bedford Pharmacy, 209 Route 101, Bedford, NH 03110, (603) 472-3919
- Manufacturer
- Bedford Pharmacy
- Category
- Drug — Injectable Steroids
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 09082015@12
- Exp10/23/2015
- 09032015@16
- Exp 10/18/2015
Distribution
Part of a larger recall action
This product is one of 13 recalled by Bedford Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · Bedford Pharmacy
See all →- HighBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P-P Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereBedford Pharmacy Recalls P-P (COBAL) Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereTestosterone Cypionate Injection Recalled Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Cypionate Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- HighTestosterone Cypionate Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-07-17
- SevereKey Pharmacy Recalls Testosterone Cypionate Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereTestosterone Cypionate Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Cypionate Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2021-11-17